Clinical and Economic Impact of Primary Hyperoxaluria: A Retrospective Claims Analysis

Home / Intelligence / Scientific Publications / Clinical and Economic Impact of Primary Hyperoxaluria: A Retrospective Claims Analysis

Primary hyperoxalurias (PH; types 1, 2, and 3) are rare genetic disorders resulting in the overproduction of oxalate in the liver and that manifest in renal complications. This study sought to quantify the healthcare resource utilization (HCRU), costs, and clinical characteristics of PH patients.


Authors

Bernd Hoppe, Abigail Silber, Gavin Miyasato, Tom Koenig, Jeffrey Skaar, Craig Langman

Journal

American Society of Nephrology; ASN Kidney Week 2020

Sign up for the latest intelligence

By signing up, you are agreeing to our Privacy Policy.